First Light Asset Management’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
Other funds holding NPCE
PCH
SCM
O
DCM
AC
First Light Asset Management's NPCE Position: Q2 2026 in Review
First Light Asset Management increased its Neuropace (NPCE) stake by 16% in Q2 2026, buying an estimated $6.46M and bringing the position to 2,861,167 shares worth $45.5M. The position accounts for 2.76% of the portfolio, ranked #15.
First Light Asset Management first reported a position in NPCE in Q1 2025 and has held it in 6 quarters since. 112 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.
- First Light Asset Management held 2,861,167 shares of Neuropace worth $45.5M as of Q2 2026.
- First Light Asset Management bought 401,201 Neuropace shares in Q2 2026, an estimated $6.46M.
- Neuropace made up 2.76% of First Light Asset Management's portfolio in Q2 2026, its #15 holding.
- First Light Asset Management first reported a position in Neuropace in Q1 2025 and has held it in 6 quarters since.
- 112 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.
Based on First Light Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.